Hold lifted on experimental drug to treat Ebola
(NEWSCHANNEL 3) - Federal health authorities are lifting a hold on an experimental drug that could treat the Ebola virus.
Canadian drug maker Tekmira Pharmaceuticals has a $140-million contract with the U.S. government to develop its "TKM Ebola."
The drug targets the virus' genetic material.
But last month the FDA halted a small study of the injection in humans because of safety concerns.
Tekmira says the agency has now "verbally confirmed" changes to the hold that may allow the company to make the drug available to patients.
There are no current licensed drugs or vaccines for the Ebola virus.